At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6,623 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Survey on Continuos Subcutaneous Insulin Infusion in Italy
In Brief
An observational study for Type 1 Diabetes. Completed, enrolled 6,623 participants across 1 site.
Detailed Summary
This is an observational, multicenter, cross sectional study, collecting clinical and metabolic informations about patients treated with CSII in Italy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartNov 2015
First PostedDec 2015
Primary CompletionDec 2017
TodayJul 2026
First PostedDec 3, 2015
Enrollment StartNov 1, 2015
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 10.6 years ago